2024 HCPCS Code G9110
Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t3-4 and/or n1-3, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
TAGS: initially disease demonstration limited squamous predominant cancers pharynx evidence larynx extent metastases established
Short Description | Onc dx head/neck t3-4 noprog |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | January 01, 2007 |
HCPCS Code Added Date | January 01, 2006 |
HCPCS Pricing Indicator Code | 00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.) |
HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- G1003 - Cdsm medicalis
- G1004 - Cdsm ndsc
- G1005 - Cdsm nia
- G1006 - Cdsm test approp
- G1007 - Cdsm aim
- G1008 - Cdsm cranberry pk
- G1009 - Cdsm sage health
- G1010 - Cdsm stanson
- G1011 - Cdsm qualified nos
- G1012 - Cdsm agilemd
- G1013 - Cdsm evidencecare
- G1014 - Cdsm inveniqa
- G1015 - Cdsm reliant
- G1016 - Cdsm speed of care
- G1017 - Cdsm healthhelp
- G1018 - Cdsm infinx
- G1019 - Cdsm logicnets
- G1020 - Cdsm curbside
- G1021 - Cdsm ehealthline
- G1022 - Cdsm intermountain